#China #Qingdao #Cancer Treatment #Patient Support #Akso Health

Akso Health Group Launches Global Patient Support Initiative

On February 3, 2026, Akso Health Group (NASDAQ: AHG) officially announced the start of an exploratory patient support program designed to enhance accessibility to medical resources for cancer patients across the globe. In partnership with the Nanning Duoling Research Institute, this initiative aims to provide specialized support by merging traditional Chinese medicine (TCM) practices with modern medical technologies.

Bridging Traditional and Modern Medicine

The newly launched program adopts an integrated approach, combining the rich heritage of TCM with the latest contemporary medical technology. Under this initiative, up to 10,000 eligible patients will be chosen to receive free treatment plans that will be executed in participating medical institutions. This dual approach intends to directly tackle the pressing medical needs of cancer patients, offering them new hope and significantly enhancing standards of medical accessibility.

Addressing Critical Needs

This patient support initiative seeks to confront the alarming reality facing over 20 million new cancer patients globally, and specifically the four million new cancer cases reported annually in China. By integrating global medical resources through collaborations with radiation oncology centers, Akso Health plans to provide comprehensive treatment solutions, targeted drug therapies, and remote consultation services. The partnership with Nanning Duoling is crucial as it provides state-of-the-art cancer diagnosis and treatment technologies, along with essential laboratory testing capabilities. Together, both organizations aim to create a sustainable model that ensures “zero-cost access” for those requiring medical services.

Creating a Closed-Loop Model

The aim of this strategic cooperation is to build a closed-loop model facilitated by the synergy of local technology and global resources. The framework ensures a full-cycle patient service, addressing critical problems that often arise such as exorbitant medical expenses, challenges with accessing healthcare services, and disparities in treatment quality. For Akso Health, this initiative is more than a program; it’s a commitment to influence systemic change in healthcare accessibility.

A Deliberate Approach to Healthcare Innovation

Yilin (Linda) Wang, CEO of Akso Health Group, emphasized the company's commitment to exploring legal and responsible avenues for improving healthcare accessibility. This initiative represents an important step, thoughtfully designed to respect regulatory boundaries while empowering licensed medical professionals. Participation in the program will be handled on a selective basis, ensuring that every potential service provided meets the necessary regulatory requirements and aligns with institutional qualifications.

Future Prospects

The initiative will undergo ongoing evaluation to assess its scalability and effectiveness. Akso Health Group believes that the long-term value of healthcare innovation resides not solely in new research, but also in the ability to implement effective solutions within actual medical frameworks. The company looks forward to harnessing collaborative synergies, leveraging institutional experiences, and enhancing system-level coordination to pursue sustainable healthcare practices.

Individuals or families interested in this patient support program can seek further information by reaching out via email at [email protected]. Applications will be processed centrally, ensuring transparency and efficiency.

About Akso Health Group

Akso Health Group was previously known as Xiaobai Maimai Inc. Currently, the organization specializes in the distribution of medical devices across China and the United States, while also managing operations linked to radiotherapy oncology centers in the U.S. In 2024, the company augmented its capabilities by acquiring interests in online medical consultation services, aiming to broaden the scope of accessible healthcare.

In summary, the Akso Health Group's initiative represents a crucial effort to carve new pathways toward improved cancer treatment accessibility, making an impactful stride within the healthcare landscape.